Ligation of TLR7 by Rheumatoid Arthritis Synovial Fluid Single Strand RNA Induces Transcription of TNFα in Monocytes

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2012 Jun 26

PMID 22730373

Citations 50

Authors

Nathan D Chamberlain

Seung-Jae Kim

Olga M Vila

Michael V Volin

Suncica Volkov

Richard M Pope

Shiva Arami

Arthur M Mandelin 2nd

Shiva Shahrara

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of the study was to characterise the expression, regulation and pathogenic role of toll-like receptor 7 (TLR7) and TLR8 in rheumatoid arthritis (RA).

Methods: Expression of TLR7 and TLR8 was demonstrated in RA, osteoarthritis (OA) and normal (NL) synovial tissues (STs) employing immunohistochemistry. The authors next examined the mechanism by which TLR7 and TLR8 ligation mediates proinflammatory response by Western blot analysis and ELISA. Expression of TLR7 and TLR8 in RA monocytes was correlated to disease activity score (DAS28) and tumour necrosis factor α (TNFα) levels. Further, the effect of TLR7 ligation in RA monocytes was determined on synovial fluid (SF)-mediated TNFα transcription.

Results: TLR7/8 are predominately expressed in RA ST lining and sublining macrophages. The authors show that NF-κB and/or PI3K pathways are essential for TLR7/8 induction of proinflammatory factors in RA peripheral blood (PB)-differentiated macrophages. Expression of TLR7 in RA monocytes shows a strong correlation with DAS28 and TNFα levels. By contrast, expression of TLR8 in these cells does not correlate with DAS28, TLR7 or TNFα levels. The authors further demonstrate that RNA from RA SF, but not RA or NL plasma, could modulate TNFα transcription from RA monocytes that can be downregulated by antagonising TLR7 ligation or degradation of single stand (ss) RNA. Thus, ssRNA present in RA SF may function as a potential endogenous ligand for TLR7.

Conclusions: These results suggest that expression of TLR7, but not TLR8, may be a predictor for RA disease activity and anti-TNFα responsiveness, and targeting TLR7 may suppress chronic progression of RA.

Citing Articles

miR-574-5p in epigenetic regulation and Toll-like receptor signaling.

Yang J Cell Commun Signal. 2024; 22(1):567.

PMID: 39593070 PMC: 11600836. DOI: 10.1186/s12964-024-01934-x.

The miR-29-3p family suppresses inflammatory osteolysis.

Shin B, Hrdlicka H, Karki S, Fraser B, Lee S, Delany A J Cell Physiol. 2024; 239(8):e31299.

PMID: 38764231 PMC: 11324400. DOI: 10.1002/jcp.31299.

Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway.

Wen Q, Zhan B, Jin L, Peng Z, Liu J, Zhu L Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543188 PMC: 10975068. DOI: 10.3390/ph17030402.

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update.

Kalliolias G, Basdra E, Papavassiliou A Biomedicines. 2024; 12(1).

PMID: 38255243 PMC: 10813148. DOI: 10.3390/biomedicines12010138.

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.

Ren W, Zhao L, Sun Y, Wang X, Shi X Mol Med. 2023; 29(1):117.

PMID: 37667233 PMC: 10478470. DOI: 10.1186/s10020-023-00717-3.

References

Lombardi V, Van Overtvelt L, Horiot S, Moingeon P . Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J Immunol. 2009; 182(6):3372-9. DOI: 10.4049/jimmunol.0801969. View

Shahrara S, Pickens S, Mandelin 2nd A, Karpus W, Huang Q, Kolls J . IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol. 2010; 184(8):4479-87. PMC: 2858914. DOI: 10.4049/jimmunol.0901942. View

Marshak-Rothstein A . Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006; 6(11):823-35. PMC: 7097510. DOI: 10.1038/nri1957. View

Severa M, Remoli M, Giacomini E, Annibali V, Gafa V, Lande R . Sensitization to TLR7 agonist in IFN-beta-preactivated dendritic cells. J Immunol. 2007; 178(10):6208-16. DOI: 10.4049/jimmunol.178.10.6208. View

Sacre S, Lo A, Gregory B, Simmonds R, Williams L, Feldmann M . Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol. 2008; 181(11):8002-9. DOI: 10.4049/jimmunol.181.11.8002. View

Cros J, Cagnard N, Woollard K, Patey N, Zhang S, Senechal B . Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010; 33(3):375-86. PMC: 3063338. DOI: 10.1016/j.immuni.2010.08.012. View

Abdollahi-Roodsaz S, Joosten L, Roelofs M, Radstake T, Matera G, Popa C . Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007; 56(9):2957-67. DOI: 10.1002/art.22848. View

Pickens S, Chamberlain N, Volin M, Pope R, Talarico N, Mandelin 2nd A . Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2011; 63(10):2884-93. PMC: 3614067. DOI: 10.1002/art.30493. View

Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol. 2004; 4(7):499-511. DOI: 10.1038/nri1391. View

10.

Schon M, Schon M . TLR7 and TLR8 as targets in cancer therapy. Oncogene. 2008; 27(2):190-9. DOI: 10.1038/sj.onc.1210913. View

11.

Huang Q, Ma Y, Adebayo A, Pope R . Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 2007; 56(7):2192-201. DOI: 10.1002/art.22707. View

12.

Hoffmann M, Skriner K, Herman S, Baumann C, Steiner C, Ospelt C . Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. J Autoimmun. 2011; 36(3-4):288-300. DOI: 10.1016/j.jaut.2011.02.007. View

13.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N . Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004; 50(5):1457-67. DOI: 10.1002/art.20219. View

14.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

15.

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S . Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004; 303(5663):1526-9. DOI: 10.1126/science.1093620. View

16.

Sorensen L, Havemose-Poulsen A, Sonder S, Bendtzen K, Holmstrup P . Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis. J Periodontol. 2008; 79(3):477-85. DOI: 10.1902/jop.2008.070309. View

17.

Huang Q, Pope R . The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep. 2009; 11(5):357-64. PMC: 2913446. DOI: 10.1007/s11926-009-0051-z. View

18.

Hoshino K, Sugiyama T, Matsumoto M, Tanaka T, Saito M, Hemmi H . IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature. 2006; 440(7086):949-53. DOI: 10.1038/nature04641. View

19.

Makela S, Osterlund P, Julkunen I . TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells. Mol Immunol. 2010; 48(4):505-15. DOI: 10.1016/j.molimm.2010.10.005. View

20.

Alexopoulou L, Holt A, Medzhitov R, Flavell R . Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001; 413(6857):732-8. DOI: 10.1038/35099560. View